Suzuki H, Kumada H, Sato A, Shiraki K, Honma Y, Kogure T, et al. Guidelines of Sho-saiko-to/Xiao-Chaihu-Tang treatment in patients with chronic hepatitis C.J Trad Med. 2000;17:95–100. Japanese.
Hirama N. Comparing current traditional Chinese medicine in Japan with Kanpo medicine of the Edo era.J Nippon Med Sch. 2013;9:218–20. Japanese.
Itoh T, Sugao M, Chijiwa T, Senda S, Oji T, Ebisawa S, et al. Clinical characteristics of side effects induced by administration of Glycyrrhizae Radix and Scutellaria Radix under the therapy based on Kampo diagnosis in our hospital.Kampo Med. 2010;61:299–307. Japanese. [DOI]
Yang L, Aronsohn A, Hart J, Jensen D. Herbal hepatoxicity from Chinese skullcap: a case report.World J Hepatol. 2012;4:231–3. [DOI] [PubMed] [PMC]
Papafragkakis C, Ona MA, Reddy M, Anand S. Acute hepatitis after ingestion of a preparation of Chinese skullcap and black catechu for joint pain.Case Reports Hepatol. 2016;2016:4356749. [DOI] [PubMed] [PMC]
Mantani N, Kogure T, Tamura J, Shimada Y, Terasawa K. Challenge tests and Kampo medicines: case report and review of the literature.Am J Chin Med. 2003;31:643–8. [DOI] [PubMed]
Sousa-Pinto B, Correia C, Gomes L, Gil-Mata S, Araújo L, Correia O, et al. HLA and delayed drug-induced hypersensitivity.Int Arch Allergy Immunol. 2016;170:163–79. [DOI] [PubMed]
Mantani N, Oka H, Watanabe T, Miyakawa K, Kimura Y. HLA gene in 5 cases of liver injury related to baikal skullcap.Indian J Clin Biochem. 2021;36:375–7. [DOI] [PubMed] [PMC]
Mantani N, Kogure T, Sakai S, Goto H, Shibahara N, Kita T, et al. Incidence and clinical features of liver injury related to Kampo (Japanese herbal) medicine in 2,496 cases between 1979 and 1999: problems of the lymphocyte transformation test as a diagnostic method.Phytomedicine. 2002;9:280–7. [DOI] [PubMed]
Mantani N, Oka H, Watanabe T, Nagasaki N. Incidence of liver injury related to Kampo medicine containing Scutellaria baicalensis at our clinic.Kampo Med. 2017;68:377–81. Japanese. [DOI]
Watanabe M, Shibuya A, Yokomori H, Koizumi W. The diagnosis of drug-induced liver injury: current diagnostic ability and future challenges of the Digestive Disease Week-Japan 2004 scale 15 years after its proposal.Intern Med. 2021;60:2557–68. [DOI] [PubMed] [PMC]
Sachs B, Fatangare A, Sickmann A, Glässner A. Lymphocyte transformation test: history and current approaches.J Immunol Methods. 2021;493:113036. [DOI] [PubMed]
Hypersensitivity to drugs.In: Beers MH, Berkow R, Bogin RM, Fletcher AJ, editors. The Merck manual of diagnosis and therapy. 17th ed. Merck; 1999. pp. 1064–7.
Mantani N, Kogure T, Tamura J, Shimada Y, Terasawa K. Lymphocyte transformation test for medicinal herbs yields false-positive results for first-visit patients.Clin Diagn Lab Immunol. 2003;10:479–80. [DOI] [PubMed] [PMC]
García-Cortés M, Stephens C, Lucena MI, Fernández-Castañer A, Andrade RJ. Causality assessment methods in drug induced liver injury: strengths and weaknesses.J Hepatol. 2011;55:683–91. [DOI] [PubMed]
Mantani N, Kogure T, Kainuma M, Shimada Y, Terasawa K. Kampo medicine and new criteria for diagnosis of drug-induced liver injury: sensitivity and specificity.Kanzo. 2004;45:345–9. [DOI]
Yamazaki K, Suzuki K, Sato K, Ouchi K, Yoshinari H, Isozaki I, et al. Herbal drug-induced fulminant hepatitis.Kanzo. 1991;32:724–9. [DOI]
